Inhibikase Therapeutics shares are trading lower. The stock may be moving on continued weakness after reporting worse-than-expected Q3 EPS results yesterday.

Inhibikase Therapeutics +3.38% Post

Inhibikase Therapeutics

IKT

3.06

3.06

+3.38%

0.00% Post

Inhibikase Therapeutics shares are trading lower. The stock may be moving on continued weakness after reporting worse-than-expected Q3 EPS results yesterday.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via